UNITED THERAPEUTICS Corp (UTHR) Other Non-Current Liabilities (2009 - 2026)

United Therapeutics (UTHR) has 18 years of Other Non-Current Liabilities data on file, last reported at $214.0 million in Q1 2026.

• Quarterly Other Non-Current Liabilities fell 0.56% year-over-year to $214.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $214.0 million (down 0.56% YoY) and the FY2025 annual result came in at $223.2 million, up 22.7% from the prior year.
• Other Non-Current Liabilities retreated to $214.0 million in Q1 2026 per UTHR's latest filing, from $223.2 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $223.2 million in Q4 2025, with the low at $67.4 million in Q3 2023.
• Average Other Non-Current Liabilities over 5 years is $137.1 million, with a median of $103.5 million recorded in 2022.
• Year-over-year, Other Non-Current Liabilities tumbled 34.88% in 2023 and soared 133.8% in 2024.
• United Therapeutics' Other Non-Current Liabilities stood at $104.6 million in 2022, then slipped by 25.62% to $77.8 million in 2023, then soared by 133.8% to $181.9 million in 2024, then grew by 22.7% to $223.2 million in 2025, then declined by 4.12% to $214.0 million in 2026.
• Business Quant data shows UTHR's Other Non-Current Liabilities at $214.0 million in Q1 2026, $223.2 million in Q4 2025, and $214.6 million in Q3 2025.